Greed, fear. I’m commenting to receive advice and listen to opinions.
Info:
- 400 shares of Intel left after buying in at $22, sold enough already to cover my original cost plus 10%
- Was going to let it ride, but I have a GREED idea. I have 2,200 shares of SLS cost basis $6.25
- The idea sell 100 shares of Intel Monday, use those funds to buy another 1000 shares of SLS.
Pertinent info: Both stocks held in nontaxable Roth and SEP IRA accounts. I’m 58, don’t “need” the money.
While I speculate a major recession and corresponding market drop, obviously I could be wrong and if it happens don’t know when. The majority of my retirement funds are in a TSP, about as safe as market funds can get. I’m not buying more bonds, than what the TSP holds.
What do ya’ll think? Sell some INTEl and double down on SLS?
Edit: quick math, if I sold 100shares of Intel at $80 per share, priofit=$8000, so 1000 SLS shares at $7 would need to trade between $15 and $20 to earn back the $8000(as profit)….so maybe this is not the best idea- as I have no idea, even IF the 3rd trial is positive, for an SLS future price. $12 at the low end? beyond $30 seems to be in the outlier territory.
Different path: Sell the Intel and SLS and take my $40,000 profit, dump it in VOO
Thanks in advance for taking your valuable time to read this far and for any feedback.
Sell some Intel to take a larger position in SLS? I’m OKAY with the greed, but I’m not sure my logic is sound.
byu/dogboneit instocks
Posted by dogboneit
13 Comments
You do you
You bought Intel at a low and want to sell it at a high– good. You bought SLS at a top and want to buy more at a new forming top– probably not so smart. I would certanly diversify out of Intel though.
Intel is dead money compared to sls. Do it
Selling intc on a dip is not smart. Buying dips is the way to go!
Ok you gotta tell me now why SLS.
Check online what biotech M&A transactions are valued at and compare that with $SLS and its current progress
I would do the opposite, sell Sls to buy more intel. But that’s me.
most of such biotechs will trap the investors AVOID
sls has 12 months of cash and an expected timeline of late ’27 or early ’28 for availability of a commercial drug.
trading a turn-around co. for one w/ 0 rev, 1 yr. of available cash, & at least 1.5 yrs to profitability.
as you said, you don’t need the cash. your odds in vegas is just as good. 🙂
I sold 2/3 of my intel position by now. But mostly to cover some heavy tax payments in a few months. Don’t want to sell low
Intel has made a parabolic move and chips (with the broader market) are about to enter a (likely short-term) correction. Will intel be higher at some point? Almost certainly. Can it retrace a huge amount of this move before doing so? Absolutely. You don’t win this game if you never pay yourself, but only you can weigh not just the risk / reward but the opportunity cost of an alternative investment.
I love the idea of Intel, however I feel it has priced itself as if its 2032 and for that reason I sold the entire position a few days ago, but will happily buy back in if it does crash. I just don’t see the short to medium term upside here (and am a little concern Trump will suggest he is going to sell some of his position when able in August as an election prop).
Your cost basis for SLS is high. In a Roth I would sit tight on both for now.
I mean I’m biased because I bought SLS around $2.06 and went more in around $5. Personally, I believe in the company, and this isn’t some random investor. I’m a physician and looking at the data so far for their drug it seems very promising. Of course, biotech stocks are always a gamble but I feel that a big player will likely buy out SLS if they continue to post positive data from their trials.
As always, this isn’t financial advice